Advanced search
Publication Cover
International Journal of Nanomedicine Volume 7, 2012 - Issue
Submit an article Journal homepage
103
Views
8
CrossRef citations to date
0
Altmetric
Original Research

FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation

Anna Szlachcic1 Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland
,
Katarzyna Pala1 Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland
,
Malgorzata Zakrzewska1 Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland
,
Piotr Jakimowicz1 Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland
,
Antoni Wiedlocha2 Centre for Cancer Biomedicine, Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
&
Jacek Otlewski1 Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, PolandCorrespondence[email protected]
Pages 5915-5927 | Published online: 29 Nov 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marcela Brito Oliveira, Mônica Villa Nova & Marcos Luciano Bruschi. (2018) A review of recent developments on micro/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer. Pharmaceutical Development and Technology 23:1, pages 1-12.
Read now
Anna Szlachcic, Malgorzata Zakrzewska, Michal Lobocki, Piotr Jakimowicz & Jacek Otlewski. (2016) Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy. Drug Design, Development and Therapy 10, pages 2547-2560.
Read now

Articles from other publishers (6)

Demi Zapata, Jordan Higgs, Hunter Wittholt, Kishore Chittimalli, Amanda E. Brooks & Pranothi Mulinti. (2022) Nanotechnology in the Diagnosis and Treatment of Osteomyelitis. Pharmaceutics 14:8, pages 1563.
Crossref
Syed Nasir Abbas Bukhari. (2022) Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials. Pharmaceutics 14:4, pages 866.
Crossref
Yadong Xu, Cheng Luo, Jieqiong Wang, Lingwu Chen, Junxing Chen, Tianfeng Chen & Qinsong Zeng. (2021) Application of nanotechnology in the diagnosis and treatment of bladder cancer. Journal of Nanobiotechnology 19:1.
Crossref
Sayali Bhave & Han Kiat Ho. (2021) Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease. Biomedicines 9:12, pages 1776.
Crossref
Mateusz A. Krzyscik, Malgorzata Zakrzewska, Vigdis Sørensen, Geir Frode Øy, Skjalg Brunheim, Ellen M. Haugsten, Gunhild M. Mælandsmo, Antoni Wiedlocha & Jacek Otlewski. (2021) Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model. Biomacromolecules 22:10, pages 4169-4180.
Crossref
Mateusz Adam Krzyscik, Małgorzata Zakrzewska & Jacek Otlewski. (2020) Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1). Molecular Pharmaceutics 17:7, pages 2734-2748.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.